KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Zoetis (ZTS) EBT (2016 - 2025)

Zoetis (ZTS) has disclosed EBT for 13 consecutive years, with $969.0 million as the latest value for Q2 2025.

  • On a quarterly basis, EBT rose 24.23% to $969.0 million in Q2 2025 year-over-year; TTM through Jun 2025 was $3.4 billion, a 15.93% increase, with the full-year FY2025 number at $3.4 billion, up 7.25% from a year prior.
  • EBT was $969.0 million for Q2 2025 at Zoetis, up from $732.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $969.0 million in Q2 2025 to a low of $506.0 million in Q4 2021.
  • A 5-year average of $716.6 million and a median of $697.0 million in 2023 define the central range for EBT.
  • Biggest YoY gain for EBT was 38.23% in 2021; the steepest drop was 19.94% in 2021.
  • Zoetis' EBT stood at $506.0 million in 2021, then grew by 17.0% to $592.0 million in 2022, then increased by 9.8% to $650.0 million in 2023, then grew by 12.62% to $732.0 million in 2024, then surged by 32.38% to $969.0 million in 2025.
  • Per Business Quant, the three most recent readings for ZTS's EBT are $969.0 million (Q2 2025), $732.0 million (Q4 2024), and $874.0 million (Q3 2024).